Viewing Study NCT03637868


Ignite Creation Date: 2025-12-24 @ 5:29 PM
Ignite Modification Date: 2026-02-24 @ 12:13 AM
Study NCT ID: NCT03637868
Status: WITHDRAWN
Last Update Posted: 2020-05-06
First Post: 2018-08-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Eribulin in Brain Metastases From HER2-negative Breast Cancer
Sponsor: Institut Paoli-Calmettes
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: ERIBRAIN-IPC 2017-014
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View